Significance of the FGFR3 mutation in Chinese patients with bladder cancer.

BACKGROUND: Bladder cancer ( BC ) is the 10th most common malignancy worldwide. The high recurrence rates of BC lead to significant treatment challenges. With the development of molecular biology techniques, research has shown that gene abnormalities are closely related to the occurrence and development of BC . This study analyzed the detection results of gene mutations in the tissue samples of BC patients and explored the relationship between fibroblast growth factor receptor 3 ( FGFR3 ) and the prognosis and recurrence of BC .

METHODS: This study examined 82 Chinese patients with BC. Of these patients, 34 underwent radical cystectomy ( RC ), and 48 underwent transurethral resection with intravesical instillation. In addition, multi-gene panel targeted next-generation sequencing ( NGS ) of the samples was performed.

RESULTS: The mutational spectra revealed that C > T was the most common base substitution. Single nucleotide polymorphism ( SNP ) and deletion ( DEL ) were the common variant types in our cohort. The top 10 mutant genes were ROS1 (37%), PIK3CA (35%), FGFR3 (34%), BRAF (34%), ERBB2 (32%), ALK (27%), RET (27%), NTRK1 (24%), MET (23%), and EGFR (18%). FGFR3 mutations were detected more frequently in non-muscle-invasive bladder cancer (stages 0a, I) patients than in muscle-invasive bladder cancer (stage II, III, and IV) patients. The top 3 altered types of FGFR3 were p.Ser249Cys, p.Tyr375Cys, and p.Arg248Cys.

CONCLUSIONS: This study examined the mutated types and frequency of FGFR3 and the prognosis of Chinese BC patients with FGFR mutations. We hope that our findings will enable clinical individualization strategies for BC patients to be optimized.